Prediction of Symptomatic Radiation Pneumonitis in Lung Cancer Patients: A Radiomics and Dosiomics Machine Learning Approach Using the Prospective Multicenter RTOG 0617 and REQUITE Trials
International Journal of Radiation Oncology*Biology*Physics · 2026-07 · 125 (4) · 1149-1159
DOI: 10.1016/j.ijrobp.2026.01.031 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-07. Verfasst von Lukas M Reuter und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, School of Medicine, TUM Klinikum Rechts der Isar, Technical University of Munich (TUM), Munich, Germany; Institute …. Hauptthemen laut MEDLINE: Radiomics, Radiation Pneumonitis, Lung Neoplasms, Machine Learning. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation, German Cancer Consortium, European Commission Seventh Framework Programme for Research and Technological Development.
Themen: Künstliche Intelligenz in der Pflege, Onkologische Pflege
Abstract (Originalsprache)
PURPOSE: Radiation-induced pneumonitis (RP) is a side effect after thoracic radiation therapy (RT). The ability to predict RP would facilitate treatment modifications. This study investigates the predictive capacity for symptomatic RP (Common Terminology Criteria for Adverse Events ≥ 2) employing Radiomics and Dosiomics models. METHODS AND MATERIALS: Computed tomography scans, along with physical and 2-Gy equivalent dose volumes (EQD2), dose-volume histograms, and clinical parameters, were evaluated for 708 multicenter lung cancer patients, among whom 89 developed RP ≥ 2. The training cohort consisted of 441 patients from the prospective RTOG 0617 trial. External validation was carried out on 267 patients from the prospective REQUITE (validating pREdictive models and biomarkers of radiotherapy toxicity to reduce side effects and improve QUalITy of lifE in cancer survivors) study. A Random Forest classifier was employed, with feature selection executed within the inner loop of a 10x5-fold nested cross-validation (nCV) utilizing the minimum-redundancy-maximum-relevance algorithm. To address class imbalances, synthetic oversampling and undersampling were implemented using SMOTE-Tomek. The QUANTEC Normal Tissue Complication Probability model served as a reference. Additionally, the experiments were stratified by subgroups (standard/high-dose and 3-dimensional conformal RT (3D-CRT)/intensity-modulated RT (IMRT). RESULTS: The best radiomics model identified in the nCV was trained on the standard-dose subgroup achieved a test ROC-AUC of 0.56. The baseline Normal Tissue Complication Probability model showed a predictive performance with a ROC-AUC of 0.56, which was largely dependent on radiation technique (ROC-AUCS: 3D-CRT: 0.75, IMRT: 0.50). The Dosiomics EQD2 model, trained on the full training cohort, attained the second-best performance in the nCV, demonstrating the same technique-dependence (ROC-AUC of 0.75 vs. 0.39). Using a Dosiomics EQD2 ensemble model trained separately on 3D-CRT and IMRT subgroups increased overall performance to a testing ROC-AUC of 0.61, outperforming other modeling strategies for IMRT, while being outperformed by clinical models for 3D-CRT. CONCLUSIONS: This prospective trial-based study reveals an overall limited predictive capacity of radiomics and dosiomics models and a large influence of radiation technique. IMRT-specific models should be investigated further.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, School of Medicine, TUM Klinikum Rechts der Isar, Technical University of Munich (TUM), Munich, Germany; Institute of Machine Learning in Biomedical Imaging (IML), Helmholtz Zentrum Mün…
- Department of Radiation Oncology, School of Medicine, TUM Klinikum Rechts der Isar, Technical University of Munich (TUM), Munich, Germany; Institute of Radiation Medicine (IRM), Helmholtz Zentrum München (HMGU) GmbH, Ge…
- Department of Radiation Oncology, School of Medicine, TUM Klinikum Rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
- Institute of Machine Learning in Biomedical Imaging (IML), Helmholtz Zentrum München (HMGU) GmbH, German Research Center for Environmental Health, Neuherberg, Germany; School of Computation, Information and Technology,…
Förderung
- German Research Foundation
- German Cancer Consortium
- European Commission Seventh Framework Programme for Research and Technological Development
Zitieren
APA
Reuter, L. M., Kraus, K. M., Fischer, S. M., Pletzer, D., Bernhardt, D., Combs, S. E., REQUITE consortium, Schnabel, J. A., & Peeken, J. C. (2026). Prediction of Symptomatic Radiation Pneumonitis in Lung Cancer Patients: A Radiomics and Dosiomics Machine Learning Approach Using the Prospective Multicenter RTOG 0617 and REQUITE Trials. International Journal of Radiation Oncology*Biology*Physics, 125(4), 1149-1159. https://doi.org/10.1016/j.ijrobp.2026.01.031
Vancouver
Reuter LM, Kraus KM, Fischer SM, Pletzer D, Bernhardt D, Combs SE, et al. Prediction of Symptomatic Radiation Pneumonitis in Lung Cancer Patients: A Radiomics and Dosiomics Machine Learning Approach Using the Prospective Multicenter RTOG 0617 and REQUITE Trials. International Journal of Radiation Oncology*Biology*Physics. 2026;125(4):1149-1159. doi:10.1016/j.ijrobp.2026.01.031
BibTeX
@article{Reuter2026,
author = {Reuter, Lukas M and Kraus, Kim M and Fischer, Stefan M and Pletzer, Danai and Bernhardt, Denise and Combs, Stephanie E and REQUITE consortium, REQUITE consortium and Schnabel, Julia A and Peeken, Jan C},
title = {Prediction of Symptomatic Radiation Pneumonitis in Lung Cancer Patients: A Radiomics and Dosiomics Machine Learning Approach Using the Prospective Multicenter RTOG 0617 and REQUITE Trials},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {125},
number = {4},
pages = {1149--1159},
doi = {10.1016/j.ijrobp.2026.01.031}
}
EUVIMED